Clinical Trials Browser

OTHER × Neoplasm Metastasis × Capecitabine × Clear all

NCT05821556 2026-04-14

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Phase 2 Recruiting

Neoplasm Metastasis

NCT00905047 2026-03-13

COLOCROSS

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT04333706 2026-03-10

EMPOWER

Phase 1/2 Recruiting

Neoplasm Metastasis, Neoplasms

NCT07407465 2026-02-17

CHIMERA

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT05472948 2025-12-17

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Phase 2 Recruiting

Gastrointestinal

Appendiceal Neoplasms, Neoplasm Metastasis

NCT04158362 2025-09-22

AMBRE

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT02419495 2025-06-04

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Phase 1 Terminated

BreastDermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT06090994 2025-05-07

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Phase 4 Recruiting

Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT02734290 2025-03-10

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

Phase 1/2 Active not recruiting

29 enrolled 12 charts

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT04534218 2024-12-20

REPROGRAM-01

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

NCT02842580 2024-07-10

HIGH-LIGHT

Phase 2 Terminated

21 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT06192680 2024-01-18

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02754011 2023-12-07

GEP14-LEECAP

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01300962 2023-12-04

Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01718873 2023-04-12

OBELICS

Phase 3 Completed

230 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02460419 2022-10-28

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

Phase 3 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT02218164 2022-10-07

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Phase 2 Completed

8 enrolled 11 charts

Carcinoma, Squamous Cell, Neoplasm Metastasis, Skin Neoplasms

NCT04355858 2022-07-26

MULAN

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT01759238 2022-07-01

OLGA

Phase 2 Terminated

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT05438706 2022-06-30

A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer

Phase 2 Unknown

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT01226732 2022-03-08

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Phase 1 Completed

23 enrolled 12 charts

Neoplasm Metastasis

NCT00321100 2022-01-12

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Phase 2 Terminated

23 enrolled 8 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT02595320 2021-12-20

X7-7

Phase 2 Unknown

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02128243 2021-03-26

MATEO

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT02550743 2021-03-12

BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

Phase 1 Terminated

7 enrolled 7 charts

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms

NCT02650752 2021-01-26

Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Phase 2/3 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01387373 2020-10-05

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01471353 2020-07-23

SorCape

Phase 2 Completed

43 enrolled 12 charts

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms

NCT02716766 2020-04-10

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT00444678 2020-04-03

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Phase 2 Completed

36 enrolled 11 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01396707 2020-01-07

Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX

Phase 2 Completed

Neoplasm Metastasis

NCT00858429 2019-09-09

Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases

Phase 1 Completed

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT03634202 2019-05-15

DESIR

Phase NA Terminated

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms

NCT02581501 2019-04-18

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

Phase 1 Withdrawn

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02007148 2019-02-27

MICADO

Phase 2 Unknown

Neoplasm Metastasis, Recurrence

NCT00483834 2019-02-15

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01996306 2019-01-08

AXEPT

Phase 3 Completed

Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01661972 2018-10-29

X-TRAP

Phase 1/2 Completed

63 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03588533 2018-07-17

HERZUMA-GC

Phase 2 Unknown

Neoplasm Metastasis

NCT01918852 2018-03-14

SALTO

Phase 3 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT00684216 2017-09-14

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Phase 2/3 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT02474186 2017-08-03

Phase II Study for Solid Metastatic Tumors

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00408772 2017-06-09

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01364493 2017-05-09

A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Recurrence, Stomach Neoplasms

NCT01640665 2016-09-16

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Digestive System Neoplasms, Neoplasm Metastasis

NCT01130805 2016-04-15

A Study of Pazopanib With CAPEOX in AGC Patients

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT01069796 2016-03-17

Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT00468585 2016-01-22

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model

Phase 1/2 Completed

62 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis